Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:605033's 5-Year Yield-on-Cost % is ranked worse than 79.17% of 144
companies
in the Agriculture industry
Industry Median: 3.015
vs SHSE:605033: 0.72
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shaanxi Meibang Pharmaceutical Group Co 5-Year Yield-on-Cost % Related Terms
SHSE:605033 vs CTVA, CF, MOS: 5-Year Yield-on-Cost % Comparison
For the Agricultural Inputs subindustry, Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Meibang Pharmaceutical Group Co 5-Year Yield-on-Cost % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost % falls into.
Shaanxi Meibang Pharmaceutical Group Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a 5-Year Yield-on-Cost % of 0.72 as of Sep. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. This is 31% below median its historical median of 1.05. Over the past decade, Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost % has ranged from 0.52 to 1.88. According to the industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #114 out of 144 companies in the Agriculture industry, placing it in the top 79.2%.
Is Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost % too high?
Shaanxi Meibang Pharmaceutical Group Co's current 5-Year Yield-on-Cost % of 0.72 is 31% below median its 10-year median of 1.05. Over the past 10 years, this metric has ranged from a low of 0.52 to a high of 1.88. The Agriculture industry median 5-Year Yield-on-Cost % is 3.02. Shaanxi Meibang Pharmaceutical Group Co's value of 0.72 is 76.1% below this industry median. Based on the distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #114 out of 144 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's 5-Year Yield-on-Cost % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Shaanxi Meibang Pharmaceutical Group Co ranks #114 out of 144 companies for 5-Year Yield-on-Cost %. This places Shaanxi Meibang Pharmaceutical Group Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.02. Shaanxi Meibang Pharmaceutical Group Co's value of 0.72 is 76.1% below this benchmark. Historically, Shaanxi Meibang Pharmaceutical Group Co's own 5-Year Yield-on-Cost % has ranged from 0.52 to 1.88 over the past decade. While the company's 10-year median is 1.05 vs. the industry median of 3.02, Shaanxi Meibang Pharmaceutical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Agriculture company?
The median 5-Year Yield-on-Cost % among Agriculture companies is 3.02, based on 144 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current 5-Year Yield-on-Cost % of 0.72 is 76.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shaanxi Meibang Pharmaceutical Group Co and its competitors. For the Agriculture industry, the median 5-Year Yield-on-Cost % is 3.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current 5-Year Yield-on-Cost % is 0.72, which is 31% below median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Fairly Valued. The stock's GF Value™ is ¥22.04, compared to a current price of ¥20.72 — trading 6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.72, which is 31% below median its 10-year median of 1.05 and 76.1% below the Agriculture industry median of 3.02. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current 5-Year Yield-on-Cost % is 0.72 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥20.72 is trading 6% below its estimated GF Value™ of ¥22.04.
GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:605033:
5-Year Yield-on-Cost %: 0.72 (31% below median its 10-year median of 1.05)
GF Value™: ¥22.04 vs. price of ¥20.72 (6% below fair value)
Industry Position: 76.1% below the Agriculture median (#114 of 144)
No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605033 has been successfully added to your 
